Skip to content
mapperlab
← Dashboard
Stock

INCY

INCYTE CORPORATION
Health CareBiotechnologyLatest close $957 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
7
27 funds tracked
Ever held
13
Current + past
New this quarter
1
Exited this quarter
1

Marquee-fund ownership over time

Nov 14, 2016May 15, 2019Nov 15, 2021May 15, 2026
Now
7

This quarter's activity

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates$73$95+30%
Renaissance Technologies$61$95+56%
Citadel Advisors$61$95+56%
Two Sigma Investments$61$95+56%
AQR Capital Management$61$95+56%
Millennium Management$61$95+56%
Point72 Asset Management re-entered$78$95+22%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
D.E. Shaw→ $95+56%
Maverick Capital 2× in & out→ $65-21%
Coatue Management→ $96+23%
Duquesne Family Office 2× in & out→ $86+13%
Viking Global Investors→ $126+20%
JANA Partners→ $117+12%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at INCYTE CORP. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
8
Filings · last 90d
18
Total on file
696
Recent SEC buffer
Most recent
Jun 8, 2026

30d / 90d windows measured from Jun 8, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 696 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · INCYTE CORPORATION

Annual figures sourced directly from INCYTE CORPORATION's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$5.14B
FY2025+21% YoY
Net income
$1.29B
FY2025+500%+ YoY
EPS (diluted)
$6.41
FY2025+500%+ YoY
Free cash flow(?)
$1.41B
FY2025+322% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for INCYTE CORP — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Point72 Asset ManagementQ2 2026open$95$95-0%
Point72 Asset ManagementQ4 2024Q1 2026$78$101+30%
Citadel AdvisorsQ3 2024open$61$95+56%
Two Sigma InvestmentsQ3 2024open$61$95+56%
D.E. ShawQ3 2024Q2 2026$61$95+56%
AQR Capital ManagementQ3 2024open$61$95+56%
Millennium ManagementQ3 2024open$61$95+56%
Renaissance TechnologiesQ3 2024open$61$95+56%
Bridgewater AssociatesQ3 2021open$73$93+27%
Maverick CapitalQ1 2021Q4 2021$82$65-21%
Coatue ManagementQ1 2020Q2 2020$78$96+23%
Maverick CapitalQ4 2019Q1 2020$86$78-9%
Duquesne Family OfficeQ2 2019Q4 2019$76$86+13%
Duquesne Family OfficeQ4 2017Q1 2018$105$88-16%
Viking Global InvestorsQ4 2016Q3 2017$105$126+20%
JANA PartnersQ4 2016Q2 2017$105$117+12%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.